Michaela Barbier

Efficacy of the Combination of Amlodipine and Valsartan in Patients With Hypertension Uncontrolled With Previous Monotherapy: The Exforge in Failure After Single Therapy (EX‐FAST) Study

Yves Allemann, Bélen Fraile, Michel Lambert et al. · Journal of Clinical Hypertension · 2008 · 113 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Efficacy and safety of initial combination therapy with amlodipine/valsartan compared with amlodipine monotherapy in black patients with stage 2 hypertension: the EX-STAND study

John M. Flack, David A. Calhoun, Lisa C. Satlin et al. · Journal of Human Hypertension · 2009 · 80 citations

Pharmacy, Pharmacology, Pharmacotherapy +11

Efficacy and safety of single therapeutic and supratherapeutic doses of indacaterol versus salmeterol and salbutamol in patients with asthma

L Brookman, Lisa J. Knowles, Michaela Barbier et al. · Current Medical Research and Opinion · 2007 · 30 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

A cost-effectiveness analysis of consolidation immunotherapy with durvalumab in stage III NSCLC responding to definitive radiochemotherapy in Switzerland

Cédric Panje, Judith E. Lupatsch, Michaela Barbier et al. · Annals of Oncology · 2020 · 26 citations · Full text

Medicine, Oncology, Pharmacoeconomics +8

A cost-effectiveness analysis of pembrolizumab with or without chemotherapy for the treatment of patients with metastatic, non-squamous non-small cell lung cancer and high PD-L1 expression in Switzerland

Michaela Barbier, E. Pardo, Cédric Panje et al. · The European Journal of Health Economics · 2021 · 20 citations · Full text

Pharmacy, Oncology, Pharmacoeconomics +17